PROVIDER PROFILE · NPI 1700877347

Enrico CaglieroMD

EndocrinologyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

892

Unique beneficiaries

—

Total services

1,191

Distinct HCPCS

Medicare payment

$86K

Peer benchmark

Total Medicare services vs. 341 Endocrinology providers in MA — near median (cohort median 496).

PRESCRIBING · PART D · 2024

Total Rx claims

612

Beneficiaries

—

Total drug cost

$657K

Distinct drugs

Brand share

92.3%

Top prescribed drugs

Tirzepatide139 claims

Semaglutide113 claims

Dulaglutide67 claims

Empagliflozin42 claims

Insulin Glargine,hum.Rec.Anlog33 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Enrico Cagliero's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THE GENERAL HOSPITAL CORPORATION	237	1,106
Tiffany Soper Nurse Practitioner · Boston, MA	16	37
Kerry Grennan Nurse Practitioner · East Boston, MA	13	28
RICHARDS, DENISE	13	20
HUGHES, ROBERT	12	52
Michelle Weil Endocrinology · Boston, MA	12	17
MASS GENERAL BRIGHAM HOME CARE, INC.	12	23
Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA	11	30

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history